|
SETD5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.592960E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.059600E-02 |
| Normal-vs-Stage2 |
4.989400E-01 |
| Normal-vs-Stage3 |
9.507400E-01 |
| Normal-vs-Stage4 |
6.105000E-01 |
| Stage1-vs-Stage2 |
4.715200E-01 |
| Stage1-vs-Stage3 |
5.813900E-02 |
| Stage1-vs-Stage4 |
2.838600E-01 |
| Stage2-vs-Stage3 |
5.318400E-01 |
| Stage2-vs-Stage4 |
8.610600E-01 |
| Stage3-vs-Stage4 |
6.464200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.528400E-01 |
| Normal-vs-AfricanAmerican |
2.054200E-01 |
| Normal-vs-Asian |
1.318470E-03 |
| Caucasian-vs-AfricanAmerican |
4.885000E-01 |
| Caucasian-vs-Asian |
3.256500E-02 |
| AfricanAmerican-vs-Asian |
9.024200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.658000E-01 |
| Normal-vs-Female |
2.531500E-02 |
| Male-vs-Female |
6.553500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.308600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.954300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.654800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.965000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.962200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.130200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.086200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.462220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.050440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.921200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.45359999998074E-06 |
| Normal-vs-Grade 2 |
2.069500E-02 |
| Normal-vs-Grade 3 |
7.776000E-01 |
| Normal-vs-Grade 4 |
5.011000E-01 |
| Grade 1-vs-Grade 2 |
1.091900E-02 |
| Grade 1-vs-Grade 3 |
1.78617999999631E-05 |
| Grade 1-vs-Grade 4 |
9.036300E-03 |
| Grade 2-vs-Grade 3 |
1.923590E-03 |
| Grade 2-vs-Grade 4 |
3.151000E-01 |
| Grade 3-vs-Grade 4 |
3.509400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.942100E-02 |
| Normal-vs-ccB subtype |
1.922240E-01 |
| ccA subtype-vs-ccB subtype |
6.421000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.463420E-01 |
| Normal-vs-N1 |
8.439000E-01 |
| N0-vs-N1 |
4.722400E-01 |
|
|
